Combination of Xuesaitong and Aspirin Based on the Antiplatelet Effect and Gastrointestinal Injury: Study Protocol for a Randomized Controlled Noninferiority Trial

BACKGROUND: Aspirin is the first-line medication for prevention and treatment of coronary heart disease (CHD). However, long-term use of aspirin resulting in gastrointestinal mucosal injury and bleeding limits the regularity of medication. Xuesaitong is a marketed Chinese medicine contained main act...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Bao-Chen, Xue, Chun-Miao, Lang, Rui, Weng, Wei-Liang, Wang, Xu-Jie, Lei, Zhen-Zhen, Zhang, Sha-Sha, Yang, Wen-Hua, Zhang, Wan-Tong, Hua, Guo-Dong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8294960/
https://www.ncbi.nlm.nih.gov/pubmed/34335822
http://dx.doi.org/10.1155/2021/5552506

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8294960/
https://www.ncbi.nlm.nih.gov/pubmed/34335822
http://dx.doi.org/10.1155/2021/5552506

Ejemplares similares